TWO · —

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) Stock

$7.10 -2.74% TWO: 4186.TWO —

—

Valuation

MetricValue
Price$7.10
Market Cap$653.40M
P/E Ratio40.33
P/B Ratio2.43
P/S Ratio1.87
EPS (TTM)$0.17
52-Week High$14.15
52-Week Low$6.73
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE6.05%
ROA2.32%
ROCE—
Gross Margin61.30%
Operating Margin-7.95%
Net Margin4.52%
Debt/Equity1.10
Current Ratio0.98

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA19.42
FCF Yield—
Quick Ratio0.88
Interest Coverage—
Return 1Y-49.82%
Return 3Y-57.10%
Return 5Y-65.78%

About Taiwan Advance Bio-Pharmaceutical Inc.

—

Taiwan Advance Bio-Pharmaceutical Inc. is led by CEO Wen-Long Su, employs 160 people, headquartered in Taipei, TW, publicly traded since 2012.

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) stock trades at $7.10 with a market capitalization of $653.40M. The stock is valued at a price-to-earnings (P/E) ratio of 40.33, price-to-book of 2.43, price-to-sales of 1.87. Over the past 52 weeks the stock has ranged between $6.73 and $14.15, and currently trades 49.8% below its 52-week high.

On profitability, Taiwan Advance Bio-Pharmaceutical Inc. generates a return on equity (ROE) of 6.05%, an operating margin of -7.95%, a net profit margin of 4.52%.

Official website: www.biotest.com.tw

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) — frequently asked questions

What is Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) stock price today?

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) is currently trading at $7.10, down 2.74% today.

What is 4186.TWO P/E ratio?

Taiwan Advance Bio-Pharmaceutical Inc.'s P/E ratio is 40.33. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.

What is 4186.TWO return on equity (ROE)?

Taiwan Advance Bio-Pharmaceutical Inc.'s return on equity (ROE) is 6.05%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.

What is Taiwan Advance Bio-Pharmaceutical Inc.'s market cap?

Taiwan Advance Bio-Pharmaceutical Inc. has a market capitalization of $653.40M.

Does 4186.TWO pay a dividend?

Taiwan Advance Bio-Pharmaceutical Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does 4186.TWO carry?

Taiwan Advance Bio-Pharmaceutical Inc. has a debt-to-equity ratio of 1.10. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is 4186.TWO's profit margin?

Taiwan Advance Bio-Pharmaceutical Inc. reports a net profit margin of 4.52% — the share of revenue left after every cost, including tax and interest.

What sector is 4186.TWO in?

Taiwan Advance Bio-Pharmaceutical Inc. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is 4186.TWO listed on?

Taiwan Advance Bio-Pharmaceutical Inc. trades on TWO under the ticker 4186.TWO.

What is 4186.TWO's 52-week range?

Over the last year Taiwan Advance Bio-Pharmaceutical Inc. has traded between $6.73 and $14.15.

Related — Stocks

HONA Honeywell Aerospace Inc. $167.90 -0.44% USDE StablecoinX Inc. $1.00 -0.01% SSMR Sunshine Silver Mining & Refining Company $14.18 +8.33% GENB Generate Biomedicines, Inc. $13.21 +6.96% PURR Hyperliquid Strategies Inc $9.85 +8.60% HAWK HawkEye 360, Inc. $13.52 +5.96% SPTX Seaport Therapeutics, Inc. $21.28 +2.16% HBNB Hotel101 Global Holdings Corp. $4.77 +7.98% WHK WhiteHawk Minerals Corp $26.81 +2.92% GMRS GMR Solutions Inc. $10.66 -1.39% AGMB AgomAb Therapeutics NV - ADRs representing one common share. $8.40 -1.98% DYNC Dynamix Corporation - Class A Ordinary Share $10.91 +0.32%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens 4186.TWO currently matches

On the figures above, Taiwan Advance Bio-Pharmaceutical Inc. passes the filters for 6 of our ready-made screens, among them Small Cap Stocks, Stocks Under $10, Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Small Cap StocksStocks Under $10Stocks Under $100Stocks Under $50High Gross Margin StocksNegative Working Capital Stocks

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.